Literature DB >> 6237890

Pharmacokinetic studies of norfloxacin in laboratory animals.

E C Gilfillan, B A Pelak, J A Bland, P F Malatesta, H H Gadebusch.   

Abstract

Pharmacokinetic studies were conducted with norfloxacin administered by the oral and subcutaneous routes to mice and rats, and by the oral route to rhesus monkeys. The compound was moderately well absorbed following oral dosing in these animal species. Serum levels in monkeys ranged from 1.0 to 2.35 micrograms/ml after an oral drug dose of 25 mg/kg of animal body weight and were similar to those in mice. Serum half-life of norfloxacin in rodents and monkeys was similar to that in humans. Concentrations of norfloxacin in tissues of mice, rats and monkeys were greater than those in serum suggesting a large volume of distribution for the drug.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237890     DOI: 10.1159/000238283

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

1.  A norfloxacin dose finding study for selective decontamination of the digestive tract in pigs.

Authors:  L A Van der Waaij; O Messerschmidt; D Van der Waaij
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

2.  Effect of oral ofloxacin on fecal bacteria in human volunteers.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

Review 3.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

4.  In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.

Authors:  P B Fernandes; D T Chu; R R Bower; K P Jarvis; N R Ramer; N Shipkowitz
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.

Authors:  Y Fukuoka; Y Ikeda; Y Yamashiro; M Takahata; Y Todo; H Narita
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.

Authors:  D Girard; T D Gootz; P R McGuirk
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

7.  Embryotoxic and teratogenic effects of norfloxacin in pregnant female albino rats.

Authors:  Mohamed Aboubakr; Mohamed Elbadawy; Ahmed Soliman; Mohamed El-Hewaity
Journal:  Adv Pharmacol Sci       Date:  2014-02-03

8.  Clinical pharmacokinetics of norfloxacin-glycine acetate after intravenous and oral administration in pigs.

Authors:  Zhi-Qiang Chang; Byung-Chol Oh; Jong-Choon Kim; Kyu-Shik Jeong; Myung-Heon Lee; Hyo-In Yun; Mi-Hyun Hwang; Seung-Chun Park
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.